** Shares of cannabis firms fall as U.S. Drug Enforcement Administration $(DEA)$ judge on Monday cancelled marijuana rescheduling hearings

** Tilray Brands falls 1.5% and Cresco Labs down 3.8%

** Toronto-listed shares of Canopy Growth down 2%, Trulieve Cannabis falls 2.7% and Curaleaf Holdings

down 3.2%

** John Mulrooney, the DEA administrative law judge, cancelled the scheduled January 21 merit-based hearing and stayed the proceedings for at least three months

** Despite marijuana being legal in dozens of U.S. states, federal law categorizes it as a schedule I drug and prohibits most conventional U.S. banks from doing business with cannabis firms

(Reporting by Pooja Menon in Bengaluru)

((Pooja.Menon@thomsonreuters.com;))